Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies

MLA

Zhang M, et al. “Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies.” Infection and Drug Resistance, vol. ume 15, Dec. 2022, pp. 7509–17. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.8f5c05cde863414e96d09ccb046d9af6&authtype=sso&custid=ns315887.

APA

Zhang M, Lu W, Xie D, Wang J, Xiao X, Pu Y, Meng J, Lyu H, & Zhao M. (2022). Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies. Infection and Drug Resistance, ume 15, 7509–7517.

Chicago

Zhang M, Lu W, Xie D, Wang J, Xiao X, Pu Y, Meng J, Lyu H, and Zhao M. 2022. “Metagenomic Next-Generation Sequencing for Diagnostically Challenging Mucormycosis in Patients with Hematological Malignancies.” Infection and Drug Resistance ume 15 (December): 7509–17. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.8f5c05cde863414e96d09ccb046d9af6&authtype=sso&custid=ns315887.